Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
Lloyd Paul Aiello, Robert L. Avery, Paul G. Arrigg, Bruce A. Keyt, Henry D. Jampel, Sabera T. Shah, Louis R. Pasquale, Hagen Thieme, Mami A. Iwamoto, John E. Park, Hung V. Nguyen, Lloyd M. Aiello, Napoleone Ferrara, and George L. King
From the Department of Ophthalmology, Beetham Eye Institute (L.P.A., P.G.A., S.T.S., L.M.A.), and the Division of Research (L.P.A., H.T., G.L.K.), Joslin Diabetes Center; the Departments of Medicine and Ophthalmology, Brigham and Women's Hospital (L.R.P., M.A.I., G.L.K.); and Harvard Medical School (L.P.A., P.G.A., S.T.S., L.R.P., H.T., M.A.I., L.M.A., G.L.K.) -- all in Boston; the Neuroscience Research Institute, University of California, Santa Barbara (R.L.A.); Genentech, Inc., San Francisco (B.A.K., J.E.P., H.V.N., N.F.); and the Department of Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore (H.D.J.).
Address reprint requests to Dr. L.P. Aiello at the Beetham Eye Institute, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215.
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., Klein, R.
(2009). Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes. NEJM
361: 40-51
[Abstract][Full Text]
Satofuka, S., Ichihara, A., Nagai, N., Noda, K., Ozawa, Y., Fukamizu, A., Tsubota, K., Itoh, H., Oike, Y., Ishida, S.
(2009). (Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation. Diabetes
58: 1625-1633
[Abstract][Full Text]
Shimada, H., Akaza, E., Yuzawa, M., Kawashima, M.
(2009). Concentration Gradient of Vascular Endothelial Growth Factor in the Vitreous of Eyes with Diabetic Macular Edema. IOVS
50: 2953-2955
[Abstract][Full Text]
Yang, L.-p., Sun, H.-l., Wu, L.-m., Guo, X.-j., Dou, H.-l., Tso, M. O. M., Zhao, L., Li, S.-m.
(2009). Baicalein Reduces Inflammatory Process in a Rodent Model of Diabetic Retinopathy. IOVS
50: 2319-2327
[Abstract][Full Text]
Prager, F, Michels, S, Kriechbaum, K, Georgopoulos, M, Funk, M, Geitzenauer, W, Polak, K, Schmidt-Erfurth, U
(2009). Intravitreal bevacizumab (Avastin(R)) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br. J. Ophthalmol.
93: 452-456
[Abstract][Full Text]
Funk, M., Kriechbaum, K., Prager, F., Benesch, T., Georgopoulos, M., Zlabinger, G. J., Schmidt-Erfurth, U.
(2009). Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with Bevacizumab. IOVS
50: 1025-1032
[Abstract][Full Text]
Chung, T.-W., Kim, S.-J., Choi, H.-J., Kim, K.-J., Kim, M.-J., Kim, S.-H., Lee, H.-J., Ko, J.-H., Lee, Y.-C., Suzuki, A., Kim, C.-H.
(2009). Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: Direct interaction of GM3 with VEGFR-2. Glycobiology
19: 229-239
[Abstract][Full Text]
Radi, Z. A.
(2009). Pathophysiology of Cyclooxygenase Inhibition in Animal Models. Toxicol Pathol
37: 34-46
[Abstract][Full Text]
Brunner, S., Schernthaner, G.-H., Satler, M., Elhenicky, M., Hoellerl, F., Schmid-Kubista, K. E., Zeiler, F., Binder, S., Schernthaner, G.
(2009). Correlation of Different Circulating Endothelial Progenitor Cells to Stages of Diabetic Retinopathy: First In Vivo Data. IOVS
50: 392-398
[Abstract][Full Text]
Smith, L. E. H.
(2008). Through The Eyes of a Child: Understanding Retinopathy through ROP The Friedenwald Lecture. IOVS
49: 5177-5182
[Full Text]
Huang, Q., Sheibani, N.
(2008). High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am. J. Physiol. Cell Physiol.
295: C1647-C1657
[Abstract][Full Text]
Cohen, M. P., Hud, E., Wu, V.-Y., Shearman, C. W.
(2008). Amelioration of Diabetes-Associated Abnormalities in the Vitreous Fluid by an Inhibitor of Albumin Glycation. IOVS
49: 5089-5093
[Abstract][Full Text]
Sears, J. E
(2008). Anti-vascular endothelial growth factor and retinopathy of prematurity. Br. J. Ophthalmol.
92: 1437-1438
[Full Text]
Hata, Y, Sassa, Y, Kita, T, Miura, M, Kano, K, Kawahara, S, Arita, R, Nakao, S, Shih, J L, Ishibashi, T
(2008). Vascular endothelial growth factor expression by hyalocytes and its regulation by glucocorticoid. Br. J. Ophthalmol.
92: 1540-1544
[Abstract][Full Text]
Krediet, R. T., Zweers, M. M., van Westrhenen, R., Zegwaard, A., Struijk, D. G.
(2008). Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?. NDT Plus
1: iv56-iv62
[Abstract][Full Text]
Yamaji, Y., Yoshida, S., Ishikawa, K., Sengoku, A., Sato, K., Yoshida, A., Kuwahara, R., Ohuchida, K., Oki, E., Enaida, H., Fujisawa, K., Kono, T., Ishibashi, T.
(2008). TEM7 (PLXDC1) in Neovascular Endothelial Cells of Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy. IOVS
49: 3151-3157
[Abstract][Full Text]
Vieitez, P., Gomez, O., Uceda, E. R, Vera, M. E., Molina-Holgado, E.
(2008). Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. Journal of Renin-Angiotensin-Aldosterone System
9: 96-102
[Abstract]
Shen, L. Q., Child, A., Weber, G. M., Folkman, J., Aiello, L. P.
(2008). Rosiglitazone and Delayed Onset of Proliferative Diabetic Retinopathy. Arch Ophthalmol
126: 793-799
[Abstract][Full Text]
Deissler, H, Deissler, H, Lang, S, Lang, G E
(2008). VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells. Br. J. Ophthalmol.
92: 839-843
[Abstract][Full Text]
Tong, Z., Yang, Z., Patel, S., Chen, H., Gibbs, D., Yang, X., Hau, V. S., Kaminoh, Y., Harmon, J., Pearson, E., Buehler, J., Chen, Y., Yu, B., Tinkham, N. H., Zabriskie, N. A., Zeng, J., Luo, L., Sun, J. K., Prakash, M., Hamam, R. N., Tonna, S., Constantine, R., Ronquillo, C. C., Sadda, S., Avery, R. L., Brand, J. M., London, N., Anduze, A. L., King, G. L., Bernstein, P. S., Watkins, S., Genetics of Diabetes and Diabetic Complication Stu, , Jorde, L. B., Li, D. Y., Aiello, L. P., Pollak, M. R., Zhang, K.
(2008). Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc. Natl. Acad. Sci. USA
105: 6998-7003
[Abstract][Full Text]
Hos, D., Bock, F., Dietrich, T., Onderka, J., Kruse, F. E., Thierauch, K.-H., Cursiefen, C.
(2008). Inflammatory Corneal (Lymph)angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation. IOVS
49: 1836-1842
[Abstract][Full Text]
Bloomgarden, Z. T.
(2008). Diabetic Retinopathy. Diabetes Care
31: 1080-1083
[Full Text]
Pieh, C, Agostini, H, Buschbeck, C, Kruger, M, Schulte-Monting, J, Zirrgiebel, U, Drevs, J, Lagreze, W A
(2008). VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br. J. Ophthalmol.
92: 689-693
[Abstract][Full Text]
Yu, L., Wu, X., Cheng, Z., Lee, C. V., LeCouter, J., Campa, C., Fuh, G., Lowman, H., Ferrara, N.
(2008). Interaction between Bevacizumab and Murine VEGF-A: A Reassessment. IOVS
49: 522-527
[Abstract][Full Text]
Kim, J. H., Kim, J. H., Yu, Y. S., Park, K. H., Kang, H. J., Lee, H.-Y., Kim, K.-W.
(2008). Antiangiogenic Effect of Deguelin on Choroidal Neovascularization. J. Pharmacol. Exp. Ther.
324: 643-647
[Abstract][Full Text]
Arevalo, J F, Maia, M, Flynn, H W Jr, Saravia, M, Avery, R L, Wu, L, Farah, M E., Pieramici, D J, Berrocal, M H, Sanchez, J G
(2008). Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br. J. Ophthalmol.
92: 213-216
[Abstract][Full Text]
Lee, J.-H., Lee, W., Kwon, O. H., Kim, J.-H., Kwon, O. W., Kim, K. H., Lim, J.-B.
(2008). Cytokine Profile of Peripheral Blood in Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy. Annals of Clinical & Laboratory Science
38: 361-367
[Abstract][Full Text]
Itaya, M., Sakurai, E., Nozaki, M., Yamada, K., Yamasaki, S., Asai, K., Ogura, Y.
(2007). Upregulation of VEGF in Murine Retina via Monocyte Recruitment after Retinal Scatter Laser Photocoagulation. IOVS
48: 5677-5683
[Abstract][Full Text]
Ameri, H., Chader, G. J., Kim, J.-G., Sadda, S. R., Rao, N. A., Humayun, M. S.
(2007). The Effects of Intravitreous Bevacizumab on Retinal Neovascular Membrane and Normal Capillaries in Rabbits. IOVS
48: 5708-5715
[Abstract][Full Text]
Zayed, M. A., Yuan, W., Leisner, T. M., Chalothorn, D., McFadden, A. W., Schaller, M. D., Hartnett, M. E., Faber, J. E., Parise, L. V.
(2007). CIB1 Regulates Endothelial Cells and Ischemia-Induced Pathological and Adaptive Angiogenesis. Circ. Res.
101: 1185-1193
[Abstract][Full Text]
You, J.-J., Yang, C.-H., Huang, J.-S., Chen, M.-S., Yang, C.-M.
(2007). Fractalkine, a CX3C Chemokine, as a Mediator of Ocular Angiogenesis. IOVS
48: 5290-5298
[Abstract][Full Text]
Matsunaga, N., Chikaraishi, Y., Shimazawa, M., Yokota, S., Hara, H.
(2007). Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo. Evid Based Complement Alternat Med
0: nem151v1-nem151
[Abstract][Full Text]
Sawada, O., Kawamura, H., Kakinoki, M., Sawada, T., Ohji, M.
(2007). Vascular Endothelial Growth Factor in Aqueous Humor Before and After Intravitreal Injection of Bevacizumab in Eyes With Diabetic Retinopathy. Arch Ophthalmol
125: 1363-1366
[Abstract][Full Text]
Forooghian, F., Razavi, R., Timms, L.
(2007). Hypoxia-inducible factor expression in human RPE cells. Br. J. Ophthalmol.
91: 1406-1410
[Abstract][Full Text]
Nishiguchi, K. M., Nakamura, M., Kaneko, H., Kachi, S., Terasaki, H.
(2007). The Role of VEGF and VEGFR2/Flk1 in Proliferation of Retinal Progenitor Cells in Murine Retinal Degeneration. IOVS
48: 4315-4320
[Abstract][Full Text]
Nagai, N., Izumi-Nagai, K., Oike, Y., Koto, T., Satofuka, S., Ozawa, Y., Yamashiro, K., Inoue, M., Tsubota, K., Umezawa, K., Ishida, S.
(2007). Suppression of Diabetes-Induced Retinal Inflammation by Blocking the Angiotensin II Type 1 Receptor or Its Downstream Nuclear Factor-{kappa}B Pathway. IOVS
48: 4342-4350
[Abstract][Full Text]
Cubbon, R. M, Rajwani, A., Wheatcroft, S. B
(2007). The impact of insulin resistance on endothelial function, progenitor cells and repair. Diabetes and Vascular Disease Research
4: 103-111
[Abstract]
Peters, S., Julien, S., Heiduschka, P., Grisanti, S., Ziemssen, F., Adler, M., Schraermeyer, U., Bartz-Schmidt, K.-U., the Tuebingen Bevacizumab Study Group,
(2007). Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. Br. J. Ophthalmol.
91: 827-831
[Abstract][Full Text]
Abu El-Asrar, A. M, Missotten, L., Geboes, K.
(2007). Expression of hypoxia-inducible factor-1{alpha} and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br. J. Ophthalmol.
91: 822-826
[Abstract][Full Text]
McLeod, D.
(2007). A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage. Br. J. Ophthalmol.
91: 677-689
[Abstract][Full Text]
Nishikiori, N., Osanai, M., Chiba, H., Kojima, T., Mitamura, Y., Ohguro, H., Sawada, N.
(2007). Glial Cell-Derived Cytokines Attenuate the Breakdown of Vascular Integrity in Diabetic Retinopathy. Diabetes
56: 1333-1340
[Abstract][Full Text]
Lu, K., Zhou, Y., Kaufman, K., Mott, R., Ma, J.-x.
(2007). Rat strain-dependent susceptibility to ischemia-induced retinopathy associated with retinal vascular endothelial growth factor regulation. J Mol Endocrinol
38: 423-432
[Abstract][Full Text]
Inan, U. U., Avci, B., Kusbeci, T., Kaderli, B., Avci, R., Temel, S. G.
(2007). Preclinical Safety Evaluation of Intravitreal Injection of Full-Length Humanized Vascular Endothelial Growth Factor Antibody in Rabbit Eyes. IOVS
48: 1773-1781
[Abstract][Full Text]
Yokoi, M., Yamagishi, S.-i., Takeuchi, M., Matsui, T., Yoshida, Y., Ohgami, K., Amano-Okamoto, T., Ohno, S.
(2007). Positive correlation between vitreous levels of advanced glycation end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently treated with photocoagulation. Br. J. Ophthalmol.
91: 397-398
[Full Text]
Arroyo, J. G
(2007). Towards a rational approach to combination therapy for neovascular age-related macular degeneration. Br. J. Ophthalmol.
91: 130-131
[Full Text]
Idris, I., Donnelly, R.
(2006). Protein kinase C {beta} inhibition: a novel therapeutic strategy for diabetic microangiopathy. Diabetes and Vascular Disease Research
3: 172-178
[Abstract]
Murakami, T., Suzuma, K., Takagi, H., Kita, M., Ohashi, H., Watanabe, D., Ojima, T., Kurimoto, M., Kimura, T., Sakamoto, A., Unoki, N., Yoshimura, N.
(2006). Time-Lapse Imaging of Vitreoretinal Angiogenesis Originating from Both Quiescent and Mature Vessels in a Novel Ex Vivo System. IOVS
47: 5529-5536
[Abstract][Full Text]
Bhisitkul, R B
(2006). Vascular endothelial growth factor biology: clinical implications for ocular treatments.. Br. J. Ophthalmol.
90: 1542-1547
[Abstract][Full Text]
Hartnett, M. E., Martiniuk, D. J., Saito, Y., Geisen, P., Peterson, L. J., McColm, J. R.
(2006). Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy. IOVS
47: 4975-4982
[Abstract][Full Text]
Maines, L. W., French, K. J., Wolpert, E. B., Antonetti, D. A., Smith, C. D.
(2006). Pharmacologic Manipulation of Sphingosine Kinase in Retinal Endothelial Cells: Implications for Angiogenic Ocular Diseases. IOVS
47: 5022-5031
[Abstract][Full Text]
Harhaj, N. S., Felinski, E. A., Wolpert, E. B., Sundstrom, J. M., Gardner, T. W., Antonetti, D. A.
(2006). VEGF Activation of Protein Kinase C Stimulates Occludin Phosphorylation and Contributes to Endothelial Permeability. IOVS
47: 5106-5115
[Abstract][Full Text]
Yamagata, M., Rook, S. L., Sassa, Y., Ma, R. C., Geraldes, P., Goddard, L., Clermont, A., Gao, B., Salti, H., Gundel, R., White, M., Feener, E. P., Aiello, L. P., King, G. L.
(2006). Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J.
20: 2058-2067
[Abstract][Full Text]
Missotten, G. S. O., Notting, I. C., Schlingemann, R. O., Zijlmans, H. J., Lau, C., Eilers, P. H. C., Keunen, J. E. E., Jager, M. J.
(2006). Vascular Endothelial Growth Factor A in Eyes With Uveal Melanoma. Arch Ophthalmol
124: 1428-1434
[Abstract][Full Text]
Kuiper, E. J., de Smet, M. D., van Meurs, J. C., Tan, H. S., Tanck, M. W. T., Oliver, N., van Nieuwenhoven, F. A., Goldschmeding, R., Schlingemann, R. O.
(2006). Association of Connective Tissue Growth Factor With Fibrosis in Vitreoretinal Disorders in the Human Eye. Arch Ophthalmol
124: 1457-1462
[Abstract][Full Text]
Zhang, S. X, Wang, J. J, Gao, G., Parke, K., Ma, J.-x.
(2006). Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.. J Mol Endocrinol
37: 1-12
[Abstract][Full Text]
Beharry, K. D. A., Modanlou, H. D., Hasan, J., Gharraee, Z., Abad-Santos, P., Sills, J. H., Jan, A., Nageotte, S., Aranda, J. V.
(2006). Comparative Effects of Early Postnatal Ibuprofen and Indomethacin on VEGF, IGF-I, and GH during Rat Ocular Development.. IOVS
47: 3036-3043
[Abstract][Full Text]
Neu, J., Afzal, A., Pan, H., Gallego, E., Li, N., Calzi, S. L., Caballero, S., Spoerri, P. E., Shaw, L. C., Grant, M. B.
(2006). The dipeptide arg-gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.. IOVS
47: 3151-3155
[Abstract][Full Text]
Chapman, J. A, Beckey, C.
(2006). Pegaptanib: A Novel Approach to Ocular Neovascularization. The Annals of Pharmacotherapy
40: 1322-1326
[Abstract][Full Text]
Masuzawa, K., Jesmin, S., Maeda, S., Zaedi, S., Shimojo, N., Miyauchi, T., Goto, K.
(2006). Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.. Exp. Biol. Med.
231: 1090-1094
[Abstract][Full Text]
Shaw, S. G., Boden, J. P., Biecker, E., Reichen, J., Rothen, B.
(2006). Endothelin Antagonism Prevents Diabetic Retinopathy in NOD Mice: A Potential Role of the Angiogenic Factor Adrenomedullin.. Exp. Biol. Med.
231: 1101-1105
[Abstract][Full Text]
Patel, J I, Hykin, P G, Cree, I A
(2006). Diabetic cataract removal: postoperative progression of maculopathy--growth factor and clinical analysis. Br. J. Ophthalmol.
90: 697-701
[Abstract][Full Text]
Amrite, A. C., Ayalasomayajula, S. P., Cheruvu, N. P. S., Kompella, U. B.
(2006). Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE2, VEGF, and Vascular Leakage.. IOVS
47: 1149-1160
[Abstract][Full Text]
Modanlou, H. D., Gharraee, Z., Hasan, J., Waltzman, J., Nageotte, S., Beharry, K. D. A.
(2006). Ontogeny of VEGF, IGF-I, and GH in Neonatal Rat Serum, Vitreous Fluid, and Retina from Birth to Weaning. IOVS
47: 738-744
[Abstract][Full Text]
Aiello, L. P., Clermont, A., Arora, V., Davis, M. D., Sheetz, M. J., Bursell, S.-E.
(2006). Inhibition of PKC {beta} by Oral Administration of Ruboxistaurin Is Well Tolerated and Ameliorates Diabetes-Induced Retinal Hemodynamic Abnormalities in Patients. IOVS
47: 86-92
[Abstract][Full Text]
Wiley, L. A., Berkowitz, B. A., Steinle, J. J.
(2006). Superior Cervical Ganglionectomy Induces Changes in Growth Factor Expression in the Rat Retina. IOVS
47: 439-443
[Abstract][Full Text]
Ojima, T., Takagi, H., Suzuma, K., Oh, H., Suzuma, I., Ohashi, H., Watanabe, D., Suganami, E., Murakami, T., Kurimoto, M., Honda, Y., Yoshimura, N.
(2006). EphrinA1 Inhibits Vascular Endothelial Growth Factor-Induced Intracellular Signaling and Suppresses Retinal Neovascularization and Blood-Retinal Barrier Breakdown. Am. J. Pathol.
168: 331-339
[Abstract][Full Text]
Yoo, M. H., Hyun, H.-J., Koh, J.-Y., Yoon, Y. H.
(2005). Riluzole Inhibits VEGF-Induced Endothelial Cell Proliferation In Vitro and Hyperoxia-Induced Abnormal Vessel Formation In Vivo. IOVS
46: 4780-4787
[Abstract][Full Text]
Akiyama, H., Mohamedali, K. A., e Silva, R. L., Kachi, S., Shen, J., Hatara, C., Umeda, N., Hackett, S. F., Aslam, S., Krause, M., Lai, H., Rosenblum, M. G., Campochiaro, P. A.
(2005). Vascular Targeting of Ocular Neovascularization with a Vascular Endothelial Growth Factor121/Gelonin Chimeric Protein. Mol. Pharmacol.
68: 1543-1550
[Abstract][Full Text]
Chen, W., Esselman, W. J., Jump, D. B., Busik, J. V.
(2005). Anti-inflammatory Effect of Docosahexaenoic Acid on Cytokine-Induced Adhesion Molecule Expression in Human Retinal Vascular Endothelial Cells. IOVS
46: 4342-4347
[Abstract][Full Text]
Yamada, N., Horikawa, Y., Oda, N., Iizuka, K., Shihara, N., Kishi, S., Takeda, J.
(2005). Genetic Variation in the Hypoxia-Inducible Factor-1{alpha} Gene Is Associated with Type 2 Diabetes in Japanese. J. Clin. Endocrinol. Metab.
90: 5841-5847
[Abstract][Full Text]
Silva, R. L. e, Saishin, Y., Saishin, Y., Akiyama, H., Kachi, S., Aslam, S., Rogers, B., Deering, T., Gong, Y. Y., Hackett, S. F., Lai, H., Frydman, B. J., Valasinas, A., Marton, L. J., Campochiaro, P. A.
(2005). Suppression and Regression of Choroidal Neovascularization by Polyamine Analogues. IOVS
46: 3323-3330
[Abstract][Full Text]
Watanabe, D., Suzuma, K., Matsui, S., Kurimoto, M., Kiryu, J., Kita, M., Suzuma, I., Ohashi, H., Ojima, T., Murakami, T., Kobayashi, T., Masuda, S., Nagao, M., Yoshimura, N., Takagi, H.
(2005). Erythropoietin as a Retinal Angiogenic Factor in Proliferative Diabetic Retinopathy. NEJM
353: 782-792
[Abstract][Full Text]
Aiello, L. P.
(2005). Angiogenic Pathways in Diabetic Retinopathy. NEJM
353: 839-841
[Full Text]
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Horig, H., Hudson, B. I., Qu, W., Weinberg, A. D., Yan, S. F., Schmidt, A. M.
(2005). The RAGE Axis in Early Diabetic Retinopathy. IOVS
46: 2916-2924
[Abstract][Full Text]
Laham, R. J., Post, M., Rezaee, M., Donnell-Fink, L., Wykrzykowska, J. J., Lee, S. U., Baim, D. S., Sellke, F. W.
(2005). TRANSENDOCARDIAL AND TRANSEPICARDIAL INTRAMYOCARDIAL FIBROBLAST GROWTH FACTOR-2 ADMINISTRATION: MYOCARDIAL AND TISSUE DISTRIBUTION. Drug Metab. Dispos.
33: 1101-1107
[Abstract][Full Text]
Ashraf, A., Mick, G., Meleth, S., Abdullatif, H., Wang, X., McCormick, K.
(2005). Effect of Insulin on Plasma Vascular Endothelial Growth Factor in Children with New-Onset Diabetes. J. Clin. Endocrinol. Metab.
90: 4920-4923
[Abstract][Full Text]
The PKC-DRS Study Group,
(2005). The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial. Diabetes
54: 2188-2197
[Abstract][Full Text]
Mohan, J S, Lip, P L, Blann, A D, Bareford, D, Lip, G Y H
(2005). The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. Br. J. Ophthalmol.
89: 815-819
[Abstract][Full Text]
Yokoi, M, Yamagishi, S-i, Takeuchi, M, Ohgami, K, Okamoto, T, Saito, W, Muramatsu, M, Imaizumi, T, Ohno, S
(2005). Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. Br. J. Ophthalmol.
89: 673-675
[Abstract][Full Text]
Miyazawa-Hoshimoto, S., Takahashi, K., Bujo, H., Hashimoto, N., Yagui, K., Saito, Y.
(2005). Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. Am. J. Physiol. Endocrinol. Metab.
288: E1128-E1136
[Abstract][Full Text]
Krady, J. K., Basu, A., Allen, C. M., Xu, Y., LaNoue, K. F., Gardner, T. W., Levison, S. W.
(2005). Minocycline Reduces Proinflammatory Cytokine Expression, Microglial Activation, and Caspase-3 Activation in a Rodent Model of Diabetic Retinopathy. Diabetes
54: 1559-1565
[Abstract][Full Text]
Lebherz, C., Maguire, A. M., Auricchio, A., Tang, W., Aleman, T. S., Wei, Z., Grant, R., Cideciyan, A. V., Jacobson, S. G., Wilson, J. M., Bennett, J.
(2005). Nonhuman Primate Models for Diabetic Ocular Neovascularization Using AAV2-Mediated Overexpression of Vascular Endothelial Growth Factor. Diabetes
54: 1141-1149
[Abstract][Full Text]
Patel, J I, Hykin, P G, Gregor, Z J, Boulton, M, Cree, I A
(2005). Angiopoietin concentrations in diabetic retinopathy. Br. J. Ophthalmol.
89: 480-483
[Abstract][Full Text]
Simons, M.
(2005). Angiogenesis: Where Do We Stand Now?. Circulation
111: 1556-1566
[Full Text]
van Wijngaarden, P., Coster, D. J., Williams, K. A.
(2005). Inhibitors of Ocular Neovascularization: Promises and Potential Problems. JAMA
293: 1509-1513
[Full Text]
Yang, W. J., Yang, D. D., Na, S., Sandusky, G. E., Zhang, Q., Zhao, G.
(2005). Dicer Is Required for Embryonic Angiogenesis during Mouse Development. J. Biol. Chem.
280: 9330-9335
[Abstract][Full Text]
Stitt, A. W., McGoldrick, C., Rice-McCaldin, A., McCance, D. R., Glenn, J. V., Hsu, D. K., Liu, F.-T., Thorpe, S. R., Gardiner, T. A.
(2005). Impaired Retinal Angiogenesis in Diabetes: Role of Advanced Glycation End Products and Galectin-3. Diabetes
54: 785-794
[Abstract][Full Text]
Feliers, D., Duraisamy, S., Barnes, J. L., Ghosh-Choudhury, G., Kasinath, B. S.
(2005). Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am. J. Physiol. Renal Physiol.
288: F521-F529
[Abstract][Full Text]
Gaudreault, J., Fei, D., Rusit, J., Suboc, P., Shiu, V.
(2005). Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration. IOVS
46: 726-733
[Abstract][Full Text]
El-Remessy, A. B., Bartoli, M., Platt, D. H., Fulton, D., Caldwell, R. B.
(2005). Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J. Cell Sci.
118: 243-252
[Abstract][Full Text]
Luttrull, J K, Musch, D C, Mainster, M A
(2005). Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br. J. Ophthalmol.
89: 74-80
[Abstract][Full Text]
Yamauchi, K., Nishimura, Y., Shigematsu, S., Takeuchi, Y., Nakamura, J., Aizawa, T., Hashizume, K.
(2004). Vascular Endothelial Cell Growth Factor Attenuates Actions of Transforming Growth Factor-{beta} in Human Endothelial Cells. J. Biol. Chem.
279: 55104-55108
[Abstract][Full Text]
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T. Jr., Feinsod, M., Guyer, D. R., the VEGF Inhibition Study in Ocular Neovasculariza,
(2004). Pegaptanib for Neovascular Age-Related Macular Degeneration. NEJM
351: 2805-2816
[Abstract][Full Text]
Ferris, F. L. III
(2004). A New Treatment for Ocular Neovascularization. NEJM
351: 2863-2865
[Full Text]
Savage, H. I., Hendrix, J. W., Peterson, D. C., Young, H., Wilkinson, C. P.
(2004). Differences in Pulsatile Ocular Blood Flow among Three Classifications of Diabetic Retinopathy. IOVS
45: 4504-4509
[Abstract][Full Text]
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., De Bruijn, E. A.
(2004). Vascular Endothelial Growth Factor and Angiogenesis. Pharmacol. Rev.
56: 549-580
[Abstract][Full Text]
Lip, P L, Chatterjee, S, Caine, G J, Hope-Ross, M, Gibson, J, Blann, A D, Lip, G Y H
(2004). Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br. J. Ophthalmol.
88: 1543-1546
[Abstract][Full Text]
Franklin, A. J., Jetton, T. L., Kuchemann, C. L., Russell, S. R., Kohn, E. C.
(2004). CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy. IOVS
45: 3756-3766
[Abstract][Full Text]
Fong, D. S., Aiello, L. P., Ferris, F. L. III, Klein, R.
(2004). Diabetic Retinopathy. Diabetes Care
27: 2540-2553
[Full Text]
Previous
